Dr. Stuart Goldstein, MD
Pediatric Nephrology (Pediatric Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- Columbia University College of Physicians and Surgeons (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 16
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: Columbia University College of Physicians and Surgeons
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Nephrology Physician primary
OH license 35.095462
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cincinnati Children's Hospital Medical Center Cincinnati, OH
Medical groups
- Children's Hospital Medical Center (711 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 16
- Services billed
- 123
- Patients’ average age
- 13
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 7 companies reported 40 payments worth $38,947 in total to this clinician.
| Vantive US Healthcare LLC | $18,103 |
|---|---|
| Baxter Healthcare | $6,618 |
| Mallinckrodt Hospital Products Inc. | $6,325 |
| Mozarc Medical US LLC | $3,844 |
| Exthera Medical Corporation | $2,025 |
| AstraZeneca Pharmaceuticals LP | $1,593 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $440 |
| Consulting Fee | $34,426 |
|---|---|
| Travel and Lodging | $3,160 |
| Food and Beverage | $761 |
| Education | $600 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Vantive US Healthcare LLC Jul 30, 2025 | Consulting Fee Renal - Acute · Renal | $5,000 |
| Baxter Healthcare Jan 8, 2025 | Consulting Fee Renal - Acute · Renal | $4,800 |
| Vantive US Healthcare LLC Jul 24, 2025 | Consulting Fee Renal - Acute · Renal | $3,600 |
| Vantive US Healthcare LLC Apr 24, 2025 | Consulting Fee Renal - Acute · Renal | $3,200 |
| Mallinckrodt Hospital Products Inc. Apr 30, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $3,019 |
| Mozarc Medical US LLC Jun 18, 2025 | Consulting Fee CARPEDIEM · HEMATOLOGY | $1,875 |
| Mallinckrodt Hospital Products Inc. Jun 11, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $1,725 |
| Vantive US Healthcare LLC Nov 4, 2025 | Consulting Fee Renal - Acute · Renal | $1,600 |
| AstraZeneca Pharmaceuticals LP May 13, 2025 | Consulting Fee | $1,593 |
| Mallinckrodt Hospital Products Inc. Mar 26, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $1,581 |
All 30 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Mozarc Medical US LLC Dec 17, 2025 | Consulting Fee CARPEDIEM · HEMATOLOGY | $1,125 |
| Vantive US Healthcare LLC Dec 1, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Pittsburgh, PA · in-kind | $520 |
| Vantive US Healthcare LLC Nov 11, 2025 | Consulting Fee Renal - Acute · Renal | $1,200 |
| Vantive US Healthcare LLC Nov 4, 2025 | Consulting Fee Renal - Acute · Renal | $1,600 |
| Vantive US Healthcare LLC Jul 30, 2025 | Consulting Fee Renal - Acute · Renal | $5,000 |
| Vantive US Healthcare LLC Jul 24, 2025 | Consulting Fee Renal - Acute · Renal | $3,600 |
| Vantive US Healthcare LLC Jul 24, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Pittsburgh, PA · in-kind | $210 |
| Vantive US Healthcare LLC Jul 24, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Pittsburgh, PA · in-kind | $50.90 |
| Vantive US Healthcare LLC Jul 15, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Pittsburgh, PA · in-kind | $455 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 23, 2025 | Consulting Fee | $440 |
| Mozarc Medical US LLC Jun 18, 2025 | Consulting Fee CARPEDIEM · HEMATOLOGY | $1,875 |
| Mallinckrodt Hospital Products Inc. Jun 11, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $1,725 |
| Mozarc Medical US LLC May 29, 2025 | Consulting Fee CARPEDIEM · HEMATOLOGY | $844 |
| AstraZeneca Pharmaceuticals LP May 13, 2025 | Consulting Fee | $1,593 |
| Mallinckrodt Hospital Products Inc. Apr 30, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $3,019 |
| Vantive US Healthcare LLC Apr 24, 2025 | Consulting Fee Renal - Acute · Renal | $3,200 |
| Vantive US Healthcare LLC Apr 23, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Columbia, SC · in-kind | $72.67 |
| Vantive US Healthcare LLC Apr 23, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Columbia, SC · in-kind | $46.00 |
| Vantive US Healthcare LLC Apr 17, 2025 | Consulting Fee Renal - Acute · Renal | $800 |
| Vantive US Healthcare LLC Apr 8, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Columbia, SC · in-kind | $653 |
| Vantive US Healthcare LLC Apr 8, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Columbia, SC · in-kind | $194 |
| Exthera Medical Corporation Apr 1, 2025 | Consulting Fee | $1,125 |
| Mallinckrodt Hospital Products Inc. Mar 26, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $1,581 |
| Exthera Medical Corporation Mar 1, 2025 | Consulting Fee | $900 |
| Baxter Healthcare Jan 8, 2025 | Consulting Fee Renal - Acute · Renal | $4,800 |
| Baxter Healthcare Jan 8, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Little Rock, AR · in-kind | $447 |
| Baxter Healthcare Jan 8, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Little Rock, AR · in-kind | $195 |
| Baxter Healthcare Jan 8, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Little Rock, AR · in-kind | $184 |
| Baxter Healthcare Jan 7, 2025 | Education Renal - Acute · Renal | $600 |
| Baxter Healthcare Jan 7, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Jonesboro, AR · in-kind | $131 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $57,089 in research payments for these studies, mostly to the institutions running them.
- Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
Vantive US Healthcare LLC · Completed · NCT06633029 - Crovalimab in aHUS pediatric patients
Genentech, Inc. - A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc. · Withdrawn · NCT04786574 - Crovalimab in aHUS adult and adolescent patients
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.